HCA Healthcare
HCA
Source: the SEC Form 13F filings of the managers we follow, latest for Q3 2026. How we use them
Managers holding
4
In their latest 13F (Q3 2026)
See who
Value held
$1.4bn
Combined value at quarter end
Last quarter
3 bought
1 sold or trimmed
Fund portfolios
1
Funds holding it
See which
Price at Q2 ’26 end
$389.89
-17.6% in the quarter
Share price change by quarter
+26.5%Q3 ’24
-26.1%Q4 ’24
+15.1%Q1 ’25
+10.9%Q2 ’25
+11.3%Q3 ’25
+9.5%Q4 ’25
+1.4%Q1 ’26
-17.6%Q2 ’26
Managers holding it, by quarter
5Q4 ’23
4Q1 ’24
4Q2 ’24
4Q3 ’24
4Q4 ’24
4Q1 ’25
4Q2 ’25
4Q3 ’25
4Q4 ’25
4Q1 ’26
4Q2 ’26
0Q3 ’26
Who holds it
| First Eagle Investment Management | 2.1%$1.3bn | Added +1.3% |
| Markel Group | 0.3%$32.9m | Added +2.3% |
| Harris Associates (Oakmark) | 0.1%$60.1m | Trimmed -2.6% |
| Brave Warrior Advisors | 0.0%$1.9m | Added +263% |
About the company
- Sector
- Health care · Services-General Medical & Surgical Hospitals, Nec
- Financial year ends
- 31 December
- Shares outstanding
- 217m at 24 Jul 2026
- SEC filings
- Annual reports and other filings on EDGAR
Revenue and profit
2013
2015
2017
$51bn2019
$59bn2021
$65bn2023
$76bn2025
| Year | Revenue | Net income |
|---|---|---|
| 2025 | $76bn | $6.8bn |
| 2024 | $71bn | $5.8bn |
| 2023 | $65bn | $5.2bn |
| 2022 | $60bn | $5.6bn |
| 2021 | $59bn | $7.0bn |
| 2020 | $52bn | $3.8bn |
| 2019 | $51bn | $3.5bn |
| 2018 | – | $3.8bn |
| 2017 | – | $2.2bn |
| 2016 | – | $2.9bn |
| 2015 | – | $2.1bn |
| 2014 | – | $1.9bn |
| 2013 | – | $1.6bn |
In fund portfolios
| First Eagle Global FundFirst Eagle Investment Management | 1.2% |